In fact, some studies carried out in the post-mortem brains of AD patients have observed that adenosine A1 receptors are decreased, even though their expression remains unaltered [39], promoting an environment of excess glutamate release that ends up in an excitotoxicity process [13]. Here, ADORA1 is linked to Alzheimer disease.